S&P 500   3,179.83 (-1.43%)
DOW   27,587.90 (-1.33%)
QQQ   218.22 (-1.43%)
AAPL   291.15 (-2.36%)
FB   199.59 (-0.56%)
MSFT   170.43 (-0.27%)
GOOGL   1,413.23 (-0.47%)
AMZN   1,978.03 (-1.56%)
CGC   19.70 (-2.96%)
NVDA   259.68 (-4.98%)
BABA   205.46 (-0.34%)
MU   52.85 (-3.93%)
GE   11.46 (-3.37%)
TSLA   791.03 (-5.13%)
AMD   47.66 (-2.97%)
T   38.06 (+0.03%)
ACB   1.50 (-3.23%)
F   7.43 (-1.85%)
NFLX   359.62 (-2.46%)
S&P 500   3,179.83 (-1.43%)
DOW   27,587.90 (-1.33%)
QQQ   218.22 (-1.43%)
AAPL   291.15 (-2.36%)
FB   199.59 (-0.56%)
MSFT   170.43 (-0.27%)
GOOGL   1,413.23 (-0.47%)
AMZN   1,978.03 (-1.56%)
CGC   19.70 (-2.96%)
NVDA   259.68 (-4.98%)
BABA   205.46 (-0.34%)
MU   52.85 (-3.93%)
GE   11.46 (-3.37%)
TSLA   791.03 (-5.13%)
AMD   47.66 (-2.97%)
T   38.06 (+0.03%)
ACB   1.50 (-3.23%)
F   7.43 (-1.85%)
NFLX   359.62 (-2.46%)
S&P 500   3,179.83 (-1.43%)
DOW   27,587.90 (-1.33%)
QQQ   218.22 (-1.43%)
AAPL   291.15 (-2.36%)
FB   199.59 (-0.56%)
MSFT   170.43 (-0.27%)
GOOGL   1,413.23 (-0.47%)
AMZN   1,978.03 (-1.56%)
CGC   19.70 (-2.96%)
NVDA   259.68 (-4.98%)
BABA   205.46 (-0.34%)
MU   52.85 (-3.93%)
GE   11.46 (-3.37%)
TSLA   791.03 (-5.13%)
AMD   47.66 (-2.97%)
T   38.06 (+0.03%)
ACB   1.50 (-3.23%)
F   7.43 (-1.85%)
NFLX   359.62 (-2.46%)
S&P 500   3,179.83 (-1.43%)
DOW   27,587.90 (-1.33%)
QQQ   218.22 (-1.43%)
AAPL   291.15 (-2.36%)
FB   199.59 (-0.56%)
MSFT   170.43 (-0.27%)
GOOGL   1,413.23 (-0.47%)
AMZN   1,978.03 (-1.56%)
CGC   19.70 (-2.96%)
NVDA   259.68 (-4.98%)
BABA   205.46 (-0.34%)
MU   52.85 (-3.93%)
GE   11.46 (-3.37%)
TSLA   791.03 (-5.13%)
AMD   47.66 (-2.97%)
T   38.06 (+0.03%)
ACB   1.50 (-3.23%)
F   7.43 (-1.85%)
NFLX   359.62 (-2.46%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Unum TherapeuticsSpring Bank PharmaceuticalsPulmatrixRegeneRx BiopharmaceuticalsVistagen Therapeutics
SymbolNASDAQ:UMRXNASDAQ:SBPHNASDAQ:PULMOTCMKTS:RGRXNASDAQ:VTGN
Price Information
Current Price$0.75$1.29$1.44$0.24$0.64
52 Week RangeBuyBuyBuyN/AHold
Analyst Ratings
Consensus RecommendationBuyBuyBuyN/AHold
Consensus Price Target$10.00$11.84$10.00N/A$2.35
% Upside from Price Target1,233.33% upside817.83% upside594.44% upsideN/A267.19% upside
Trade Information
Market Cap$22.98 million$19.65 million$29.19 million$34.69 million$33.42 million
Beta0.970.531.290.34-0.43
Average Volume238,094270,2121,748,198106,930317,403
Sales & Book Value
Annual Revenue$9.73 millionN/A$150,000.00$70,000.00$1.25 million
Price / Sales2.30N/A191.95457.5224.56
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$2.01 per share$2.16 per share$2.32 per share($0.02) per share$0.17 per share
Price / Book0.37N/A0.62-12.003.76
Profitability
Net Income$-34,530,000.00$-24,100,000.00$-20,560,000.00$-1,990,000.00$-24,590,000.00
EPS($1.39)($1.47)($4.98)N/A($0.90)
Trailing P/E RatioN/AN/AN/A0.00N/A
Forward P/E RatioN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-388.07%N/AN/A-1,735.53%N/A
Return on Equity (ROE)-96.07%-60.99%-97.87%N/A-1,451.45%
Return on Assets (ROA)-58.06%-42.47%-54.40%-161.42%-226.50%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.17%0.62%N/AN/A2.44%
Current Ratio1.96%10.73%2.46%4.25%0.47%
Quick Ratio1.96%10.72%2.46%4.25%0.47%
Ownership Information
Institutional Ownership Percentage31.69%21.45%7.96%0.18%5.23%
Insider Ownership Percentage31.30%12.70%9.30%10.90%12.34%
Miscellaneous
Employees56292239
Shares Outstanding29.89 million16.51 million20.00 million133.44 million47.96 million
Next Earnings Date3/26/2020 (Estimated)5/4/2020 (Estimated)2/25/2020 (Estimated)4/3/2020 (Estimated)6/23/2020 (Estimated)
OptionableNot OptionableNot OptionableOptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel